Clinical Trial Update: A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of oral MKC-1 in patients with ovarian or endometrial cancer has completed. The trial was sponsored by CASI Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• MKC-1

Snippet

Sponsor: CASI Pharmaceuticals, Inc. | Conditions: Ovarian Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED